NEU-411

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameNEU-411
Drug Alias NameNEU-411
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeucine-rich repeat serine/threonine-protein kinase 2 inhibitors
TargetsLeucine-rich repeat serine/threonine-protein kinase 2
Therapy Area/IndicationsParkinson DiseaseParkinsonian Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandNew Zealand +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeuron23 Inc
China Registration ClassN/A

Develop Information

Active CompaniesRoche Diagnostic LtdNeuron23 Inc
Inactive CompaniesN/A
Active IndicationsParkinson DiseaseParkinsonian Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A